SecBot SecBot
SECBOTREPLAY Home › Report › DYN

DYN · Two Dyne Therapeutics directors, Jason Rhodes and Dirk Kersten, sold a…

Dyne Therapeutics, Inc. · CLUSTER filed Apr 22, 2026 at 18:27 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Apr 22, 2026 at 18:27 ET

Two Dyne Therapeutics directors, Jason Rhodes and Dirk Kersten, sold a combined $423K in open-market stock over a 2-day window (April 22-23, 2026). The sales represent approximately 0.014% of the company's $3.0B market cap, a trivial amount with no material economic signal. This follows a larger cluster of director sales totaling $4.97M over the prior week, but the current cluster is too small to indicate a change in outlook.

  • Two directors sold a combined $423K in open-market transactions
  • Sales represent ~0.014% of DYN's $3.0B market cap
  • Director Jason Rhodes sold $370K; Director Dirk Kersten sold $53K
  • All transactions were open-market sales (code S)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access